Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDIN8bio Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.62 | -$0.62 | -$0.62 |
| Q2 2026 | 2 | -$0.34 | -$0.34 | -$0.34 |
| Q3 2026 | 2 | -$0.31 | -$0.31 | -$0.31 |
| Q4 2026 | 2 | -$0.33 | -$0.33 | -$0.33 |
| Q1 2027 | 1 | -$0.33 | -$0.33 | -$0.33 |
| Q2 2027 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q3 2027 | 1 | -$0.35 | -$0.35 | -$0.35 |
| Q4 2027 | 1 | -$0.22 | -$0.22 | -$0.22 |
IN8bio Inc Earnings Date And Information
IN8bio Inc last posted its earnings results on Thursday, August 6th, 2026. The company reported $-0.25 earnings per share for the quarter, topping analysts' consensus estimates of $-0.34367 by $0.09367. The company had revenue of 0 for the quarter and had revenue of 0 for the year. IN8bio Inc has generated $-4 earnings per share over the last year ($-4.44 diluted earnings per share) and currently has a price-to-earnings ratio of -0.68. IN8bio Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
IN8bio Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/06/2026 | Q2 2026 | -$0.34 | -$0.25 | 0.09 | $0 | $0 |
| 05/07/2026 | Q1 2026 | -$0.59 | -$0.26 | 0.33 | $0 | $0 |
| 03/12/2026 | Q4 2025 | -$0.18 | -$0.51 | -0.33 | $16.00 M | $0 |
| 11/06/2025 | Q3 2025 | -$1.20 | -$0.85 | 0.35 | $5.80 M | $0 |
| 08/07/2025 | Q2 2025 | -$1.50 | -$1.24 | 0.26 | N/A | $0 |
| 05/07/2025 | Q1 2025 | -$1.80 | -$1.99 | -0.19 | N/A | $0 |
| 03/13/2025 | Q4 2024 | -$0.07 | -$2.55 | -2.48 | N/A | $0 |
| 11/12/2024 | Q3 2024 | -$4.20 | -$4.49 | -0.29 | N/A | $0 |
| 08/08/2024 | Q2 2024 | -$4.80 | -$5.74 | -0.94 | N/A | $0 |
| 05/09/2024 | Q1 2024 | -$0.18 | -$5.93 | -5.75 | N/A | $0 |
| 03/14/2024 | Q4 2023 | -$4.60 | -$6.37 | -1.77 | N/A | $0 |
| 11/09/2023 | Q3 2023 | -$7.35 | -$6.82 | 0.53 | N/A | $0 |
| 08/10/2023 | Q2 2023 | -$0.28 | -$8.13 | -7.85 | N/A | $0 |
| 05/12/2023 | Q1 2023 | -$0.32 | -$9.13 | -8.81 | N/A | $0 |
| 03/30/2023 | Q4 2022 | -$0.32 | -$9.53 | -9.21 | N/A | $0 |
| 11/10/2022 | Q3 2022 | -$0.29 | -$10.25 | -9.96 | N/A | $0 |
| 08/12/2022 | Q2 2022 | -$0.29 | -$11.44 | -11.15 | N/A | $0 |
| 05/12/2022 | Q1 2022 | -$0.33 | -$9.81 | -9.48 | N/A | $0 |
| 03/17/2022 | Q4 2021 | -$0.27 | -$9.34 | -9.08 | N/A | $0 |
| 11/10/2021 | Q3 2021 | -$9.91 | -$5.42 | 4.49 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
IN8bio Inc Earnings: FAQ's
In the previous quarter, IN8bio Inc (:INAB) reported $-0.25 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.34367 by $0.09367.
The conference call for IN8bio Inc's latest earnings report can be listened to online.
The conference call transcript for IN8bio Inc's latest earnings report can be read online.
IN8bio Inc (:INAB) has a recorded net income of $-19,440,000.IN8bio Inc has generated $-4.44 earnings per share over the last four quarters.
IN8bio Inc (:INAB) has a price-to-earnings ratio of -0.68 and price/earnings-to-growth ratio is -0.